OKI-006
Product Specifications
UNSPSC Description
OKI-006 is a potent and orally active inhibitor of histone deacetylase (HDAC). OKI-006 is a unique congener of the natural product HDAC inhibitor largazole. Histone deacetylases (HDACs) play critical roles in epigenomic regulation, and histone acetylation is dysregulated in many human cancers. OKI-006 has the potential for the research of cancer disease[1].
Target Antigen
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/oki-006.html
Solubility
10 mM in DMSO
Smiles
SCC/C=C/[C@@H]1CC(NCC2=NC(C(NC(C)(C(N[C@H](C(O1)=O)C(C)C)=O)C)=O)=CS2)=O
Molecular Weight
482.62
References & Citations
[1]Diamond JR, et al. Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Mol Cancer Ther. 2022;21(3):397-406.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-144893/OKI-006-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-144893/
Clinical Information
No Development Reported
CAS Number
1315334-23-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6199827-01 0.1 mL
C4orf43 (TMA16, Translation Machinery-associated Protein 16, FLJ11184) (MaxLight 490)
Ask
View Details MBS6199827-02 5x 0.1 mL
C4orf43 (TMA16, Translation Machinery-associated Protein 16, FLJ11184) (MaxLight 490)
Ask
View Details ARP40619_P050-FITC 100 µL
MIA2 Antibody - N-terminal region: FITC (ARP40619_P050-FITC)
Ask
View Details